229 related articles for article (PubMed ID: 23906810)
1. Early growth response 3 (Egr-3) is induced by transforming growth factor-β and regulates fibrogenic responses.
Fang F; Shangguan AJ; Kelly K; Wei J; Gruner K; Ye B; Wang W; Bhattacharyya S; Hinchcliff ME; Tourtellotte WG; Varga J
Am J Pathol; 2013 Oct; 183(4):1197-1208. PubMed ID: 23906810
[TBL] [Abstract][Full Text] [Related]
2. Smad-independent transforming growth factor-beta regulation of early growth response-1 and sustained expression in fibrosis: implications for scleroderma.
Bhattacharyya S; Chen SJ; Wu M; Warner-Blankenship M; Ning H; Lakos G; Mori Y; Chang E; Nihijima C; Takehara K; Feghali-Bostwick C; Varga J
Am J Pathol; 2008 Oct; 173(4):1085-99. PubMed ID: 18772333
[TBL] [Abstract][Full Text] [Related]
3. The early growth response gene Egr2 (Alias Krox20) is a novel transcriptional target of transforming growth factor-β that is up-regulated in systemic sclerosis and mediates profibrotic responses.
Fang F; Ooka K; Bhattacharyya S; Wei J; Wu M; Du P; Lin S; Del Galdo F; Feghali-Bostwick CA; Varga J
Am J Pathol; 2011 May; 178(5):2077-90. PubMed ID: 21514423
[TBL] [Abstract][Full Text] [Related]
4. p300 is elevated in systemic sclerosis and its expression is positively regulated by TGF-β: epigenetic feed-forward amplification of fibrosis.
Ghosh AK; Bhattacharyya S; Lafyatis R; Farina G; Yu J; Thimmapaya B; Wei J; Varga J
J Invest Dermatol; 2013 May; 133(5):1302-10. PubMed ID: 23303459
[TBL] [Abstract][Full Text] [Related]
5. Egr-1 induces a profibrotic injury/repair gene program associated with systemic sclerosis.
Bhattacharyya S; Sargent JL; Du P; Lin S; Tourtellotte WG; Takehara K; Whitfield ML; Varga J
PLoS One; 2011; 6(9):e23082. PubMed ID: 21931594
[TBL] [Abstract][Full Text] [Related]
6. Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma.
Lakos G; Takagawa S; Chen SJ; Ferreira AM; Han G; Masuda K; Wang XJ; DiPietro LA; Varga J
Am J Pathol; 2004 Jul; 165(1):203-17. PubMed ID: 15215176
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
Bhattacharyya S; Ghosh AK; Pannu J; Mori Y; Takagawa S; Chen G; Trojanowska M; Gilliam AC; Varga J
Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 4 signaling augments transforming growth factor-β responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma.
Bhattacharyya S; Kelley K; Melichian DS; Tamaki Z; Fang F; Su Y; Feng G; Pope RM; Budinger GR; Mutlu GM; Lafyatis R; Radstake T; Feghali-Bostwick C; Varga J
Am J Pathol; 2013 Jan; 182(1):192-205. PubMed ID: 23141927
[TBL] [Abstract][Full Text] [Related]
9. A non-Smad mechanism of fibroblast activation by transforming growth factor-beta via c-Abl and Egr-1: selective modulation by imatinib mesylate.
Bhattacharyya S; Ishida W; Wu M; Wilkes M; Mori Y; Hinchcliff M; Leof E; Varga J
Oncogene; 2009 Mar; 28(10):1285-97. PubMed ID: 19151753
[TBL] [Abstract][Full Text] [Related]
10. The transcriptional cofactor nab2 is induced by tgf-Beta and suppresses fibroblast activation: physiological roles and impaired expression in scleroderma.
Bhattacharyya S; Wei J; Melichian DS; Milbrandt J; Takehara K; Varga J
PLoS One; 2009 Oct; 4(10):e7620. PubMed ID: 19888474
[TBL] [Abstract][Full Text] [Related]
11. A synthetic PPAR-γ agonist triterpenoid ameliorates experimental fibrosis: PPAR-γ-independent suppression of fibrotic responses.
Wei J; Zhu H; Komura K; Lord G; Tomcik M; Wang W; Doniparthi S; Tamaki Z; Hinchcliff M; Distler JH; Varga J
Ann Rheum Dis; 2014 Feb; 73(2):446-54. PubMed ID: 23515440
[TBL] [Abstract][Full Text] [Related]
12. Egr-1: new conductor for the tissue repair orchestra directs harmony (regeneration) or cacophony (fibrosis).
Bhattacharyya S; Fang F; Tourtellotte W; Varga J
J Pathol; 2013 Jan; 229(2):286-97. PubMed ID: 23132749
[TBL] [Abstract][Full Text] [Related]
13. The Histone Deacetylase Sirtuin 1 Is Reduced in Systemic Sclerosis and Abrogates Fibrotic Responses by Targeting Transforming Growth Factor β Signaling.
Wei J; Ghosh AK; Chu H; Fang F; Hinchcliff ME; Wang J; Marangoni RG; Varga J
Arthritis Rheumatol; 2015 May; 67(5):1323-34. PubMed ID: 25707573
[TBL] [Abstract][Full Text] [Related]
14. The early-immediate gene EGR-1 is induced by transforming growth factor-beta and mediates stimulation of collagen gene expression.
Chen SJ; Ning H; Ishida W; Sodin-Semrl S; Takagawa S; Mori Y; Varga J
J Biol Chem; 2006 Jul; 281(30):21183-21197. PubMed ID: 16702209
[TBL] [Abstract][Full Text] [Related]
15. Sustained activation of fibroblast transforming growth factor-beta/Smad signaling in a murine model of scleroderma.
Takagawa S; Lakos G; Mori Y; Yamamoto T; Nishioka K; Varga J
J Invest Dermatol; 2003 Jul; 121(1):41-50. PubMed ID: 12839562
[TBL] [Abstract][Full Text] [Related]
16. Essential roles for early growth response transcription factor Egr-1 in tissue fibrosis and wound healing.
Wu M; Melichian DS; de la Garza M; Gruner K; Bhattacharyya S; Barr L; Nair A; Shahrara S; Sporn PH; Mustoe TA; Tourtellotte WG; Varga J
Am J Pathol; 2009 Sep; 175(3):1041-55. PubMed ID: 19679873
[TBL] [Abstract][Full Text] [Related]
17. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
[TBL] [Abstract][Full Text] [Related]
18. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
[TBL] [Abstract][Full Text] [Related]
19. Early growth response transcription factors: key mediators of fibrosis and novel targets for anti-fibrotic therapy.
Bhattacharyya S; Wu M; Fang F; Tourtellotte W; Feghali-Bostwick C; Varga J
Matrix Biol; 2011 May; 30(4):235-42. PubMed ID: 21511034
[TBL] [Abstract][Full Text] [Related]
20. The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy.
Fang F; Liu L; Yang Y; Tamaki Z; Wei J; Marangoni RG; Bhattacharyya S; Summer RS; Ye B; Varga J
Arthritis Res Ther; 2012 Oct; 14(5):R229. PubMed ID: 23092446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
